Afuco™ Anti-CGRP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-428CQ)

Customer Review

There are currently no Customer reviews or questions for AFC-TAB-428CQ. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Biosimilar Overview

Please refer to Fremanezumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Fremanezumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Fremanezumab"

DrugMonitor™ Anti-Fremanezumab Antibody (VS-1224-YC489)

Fremanezumab is a humanized monoclonal antibody targeting human calcitonin gene-related peptide (CGRP) for migraine headache prevention. The DrugMonitor™ Anti-Fremanezumab Antibody (VS-1224-YC489) is an anti-drug antibody (ADA) against Fremanezumab. This drug-based antibody is raised in mice immunized with the Fremanezumab. The anti-Fremanezumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Fremanezumab in samples.

See other products for "CALCA and CALCB"

Select a product category from the dropdown menu below to view related products.